CB1 and CB2 cannabinoid receptors — Drug Target

3 drugs 2 marketed 1 in Phase 3

All drugs that target CB1 and CB2 cannabinoid receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Synthetic cannabinoid

Marketed (2)

Phase 3 pipeline (1)